A supplement of two L. reuteri probiotic strains can significantly reduce days of fever and severity of pain in children being treated for upper respiratory tract infections thanks to their anti-inflammatory effects, according to a new clinical trial.
A combination of five probiotic strains may slash the symptoms of viral upper respiratory tract infections (URTI) by over 25%, with people over 45 experiencing greater benefits, says new data from the PROMAGEN study.